560 related articles for article (PubMed ID: 23916847)
1. Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease.
Murphy SK; Yang H; Moylan CA; Pang H; Dellinger A; Abdelmalek MF; Garrett ME; Ashley-Koch A; Suzuki A; Tillmann HL; Hauser MA; Diehl AM
Gastroenterology; 2013 Nov; 145(5):1076-87. PubMed ID: 23916847
[TBL] [Abstract][Full Text] [Related]
2. Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease.
Moylan CA; Pang H; Dellinger A; Suzuki A; Garrett ME; Guy CD; Murphy SK; Ashley-Koch AE; Choi SS; Michelotti GA; Hampton DD; Chen Y; Tillmann HL; Hauser MA; Abdelmalek MF; Diehl AM
Hepatology; 2014 Feb; 59(2):471-82. PubMed ID: 23913408
[TBL] [Abstract][Full Text] [Related]
3. Targeted-bisulfite sequence analysis of the methylation of CpG islands in genes encoding PNPLA3, SAMM50, and PARVB of patients with non-alcoholic fatty liver disease.
Kitamoto T; Kitamoto A; Ogawa Y; Honda Y; Imajo K; Saito S; Yoneda M; Nakamura T; Nakajima A; Hotta K
J Hepatol; 2015 Aug; 63(2):494-502. PubMed ID: 25776890
[TBL] [Abstract][Full Text] [Related]
4. Differentially methylated loci in NAFLD cirrhosis are associated with key signaling pathways.
Gerhard GS; Malenica I; Llaci L; Chu X; Petrick AT; Still CD; DiStefano JK
Clin Epigenetics; 2018 Jul; 10(1):93. PubMed ID: 30005700
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis.
Alonso C; Fernández-Ramos D; Varela-Rey M; Martínez-Arranz I; Navasa N; Van Liempd SM; Lavín Trueba JL; Mayo R; Ilisso CP; de Juan VG; Iruarrizaga-Lejarreta M; delaCruz-Villar L; Mincholé I; Robinson A; Crespo J; Martín-Duce A; Romero-Gómez M; Sann H; Platon J; Van Eyk J; Aspichueta P; Noureddin M; Falcón-Pérez JM; Anguita J; Aransay AM; Martínez-Chantar ML; Lu SC; Mato JM
Gastroenterology; 2017 May; 152(6):1449-1461.e7. PubMed ID: 28132890
[TBL] [Abstract][Full Text] [Related]
6. Altered DNA Methylation Sites in Peripheral Blood Leukocytes from Patients with Simple Steatosis and Nonalcoholic Steatohepatitis (NASH).
Wu J; Zhang R; Shen F; Yang R; Zhou D; Cao H; Chen G; Pan Q; Fan J
Med Sci Monit; 2018 Oct; 24():6946-6967. PubMed ID: 30270343
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease.
Pirola CJ; Gianotti TF; Burgueño AL; Rey-Funes M; Loidl CF; Mallardi P; Martino JS; Castaño GO; Sookoian S
Gut; 2013 Sep; 62(9):1356-63. PubMed ID: 22879518
[TBL] [Abstract][Full Text] [Related]
8. Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity.
Di Mauro S; Scamporrino A; Petta S; Urbano F; Filippello A; Ragusa M; Di Martino MT; Scionti F; Grimaudo S; Pipitone RM; Privitera G; Di Pino A; Scicali R; Valenti L; Dongiovanni P; Fracanzani A; Rabuazzo AM; Craxì A; Purrello M; Purrello F; Piro S
Liver Int; 2019 Sep; 39(9):1742-1754. PubMed ID: 31169972
[TBL] [Abstract][Full Text] [Related]
9. Validation of Serum Test for Advanced Liver Fibrosis in Patients With Nonalcoholic Steatohepatitis.
Loomba R; Jain A; Diehl AM; Guy CD; Portenier D; Sudan R; Singh S; Faulkner C; Richards L; Hester KD; Okada L; Li XJ; Mimms L; Abdelmalek MF
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1867-1876.e3. PubMed ID: 30448594
[TBL] [Abstract][Full Text] [Related]
10. NAFLD: Profiling NAFLD--liver gene expression and DNA methylation patterns to characterize disease severity.
Ray K
Nat Rev Gastroenterol Hepatol; 2013 Oct; 10(10):565. PubMed ID: 23958603
[No Abstract] [Full Text] [Related]
11. Identification of the genomic region under epigenetic regulation during non-alcoholic fatty liver disease progression.
Hotta K; Kitamoto T; Kitamoto A; Ogawa Y; Honda Y; Kessoku T; Yoneda M; Imajo K; Tomeno W; Saito S; Nakajima A
Hepatol Res; 2018 Feb; 48(3):E320-E334. PubMed ID: 29059699
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.
Teufel A; Itzel T; Erhart W; Brosch M; Wang XY; Kim YO; von Schönfels W; Herrmann A; Brückner S; Stickel F; Dufour JF; Chavakis T; Hellerbrand C; Spang R; Maass T; Becker T; Schreiber S; Schafmayer C; Schuppan D; Hampe J
Gastroenterology; 2016 Sep; 151(3):513-525.e0. PubMed ID: 27318147
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide analysis of DNA methylation in human peripheral leukocytes identifies potential biomarkers of nonalcoholic fatty liver disease.
Zhang RN; Pan Q; Zheng RD; Mi YQ; Shen F; Zhou D; Chen GY; Zhu CY; Fan JG
Int J Mol Med; 2018 Jul; 42(1):443-452. PubMed ID: 29568887
[TBL] [Abstract][Full Text] [Related]
14. Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver Disease.
Pacana T; Cazanave S; Verdianelli A; Patel V; Min HK; Mirshahi F; Quinlivan E; Sanyal AJ
PLoS One; 2015; 10(8):e0136822. PubMed ID: 26322888
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic steatohepatitis is associated with a state of betaine-insufficiency.
Sookoian S; Puri P; Castaño GO; Scian R; Mirshahi F; Sanyal AJ; Pirola CJ
Liver Int; 2017 Apr; 37(4):611-619. PubMed ID: 27614103
[TBL] [Abstract][Full Text] [Related]
16. A targeted analysis reveals relevant shifts in the methylation and transcription of genes responsible for bile acid homeostasis and drug metabolism in non-alcoholic fatty liver disease.
Schiöth HB; Boström A; Murphy SK; Erhart W; Hampe J; Moylan C; Mwinyi J
BMC Genomics; 2016 Jun; 17():462. PubMed ID: 27301979
[TBL] [Abstract][Full Text] [Related]
17. DNA Methylation in Nonalcoholic Fatty Liver Disease.
Hyun J; Jung Y
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143364
[TBL] [Abstract][Full Text] [Related]
18. Identification of differentially methylated region (DMR) networks associated with progression of nonalcoholic fatty liver disease.
Hotta K; Kitamoto A; Kitamoto T; Ogawa Y; Honda Y; Kessoku T; Yoneda M; Imajo K; Tomeno W; Saito S; Nakajima A
Sci Rep; 2018 Sep; 8(1):13567. PubMed ID: 30206277
[TBL] [Abstract][Full Text] [Related]
19. Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease.
Hardy T; Zeybel M; Day CP; Dipper C; Masson S; McPherson S; Henderson E; Tiniakos D; White S; French J; Mann DA; Anstee QM; Mann J
Gut; 2017 Jul; 66(7):1321-1328. PubMed ID: 27002005
[TBL] [Abstract][Full Text] [Related]
20. Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study.
Wegermann K; Henao R; Diehl AM; Murphy SK; Abdelmalek MF; Moylan CA
PLoS One; 2018; 13(9):e0204308. PubMed ID: 30265706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
